Publications

5674 Results

Energy from fat is associated with obesity in US men: results from the prostate cancer prevention trial

Authors
J Satia-Abouta;RE Patterson;RN Schiller;AR Kristal
Journal / Conference
Preventive Medicine 34:493-501
Year
2002
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

SWOG-9510: Evaluation of topotecan in hormone-refractory prostate cancer: a Southwest Oncology Group study

Authors
CE Klein;CM Tangen;TJ Braun;MHA Hussain;DM Peereboom;CR Nichols;SE Rivkin;SR Dakhil;ED Crawford
Journal / Conference
The Prostate 52:264-268
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9510

Cyclosporine inhibitionof P-glycoprotein in chronic myeloid leukemia blast phase

Authors
AF List;KJ Kopecky;CL Willman;DR Head;ML Slovak;D Douer;SR Dakhil;FR Appelbaum
Journal / Conference
Blood 100(5):1910-1912
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9032

21q22-balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop

Authors
ML Slovak;V Bedell;L Popplewell;DA Arber;C Schoch;R Slater
Journal / Conference
Genes Chromosomes & Cancer 33:379-394
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007

Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study

Authors
RP Whitehead;D Lew;RC Flanigan;GR Weiss;V Roy;LM Glode;SR Dakhil;ED Crawford
Journal / Conference
Journal of Immunotherapy 25(4):352-358
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9230

Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent: initial results from Intergroup trial 0100 (SWOG-8814).

Authors
KS Albain;SJ Green;PM Ravdin;CD Cobau;EG Levine;JN Ingle;KI Pritchard;DJ Schneider;MD Abeloff;L Norton;IC Henderson;D Lew;RB Livingston;S Martino;CK Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 21:37a(#143)
Year
2002
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Cytogenetic and flow cytometric results in advanced renal cell carcinoma: a Southwest Oncology Group study

Authors
RP Whitehead;C Tangen;SR Wolman;RC Flanigan;TV Shankey;ML Slovak;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 21:147b(#2400)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9023

HLA-A2 and/or HLA-C3 expression defines a subset of T3N0 melanoma patients with improved overall survival from melacine vaccine: an updated analysis of SWOG 9035.

Authors
JA Sosman;JM Unger;PY Liu;R Kempf;L Flaherty;J Thompson;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 21:340a(#1359)
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Phase III comparison of adjuvant high-dose doxorubicin plus cyclophosphamide (AC) versus sequential doxorubicin followed by chyclophosphamide (A->C) in breast cancer patients with 0-3 positive nodes (Intergroup 0137)

Authors
CM Haskell;SJ Green;GW Sledge Jr;CL Shapiro;JN Ingle;D Lew;S Martino;R Livingston;CK Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 21:36a(#142)
Year
2002
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

Induction chemotherapy followed by chemoradiation for organ preservation in patients (pts) with advanced resectable cancer of the base of tongue (BOT) and hypopharynx (HP): a Southwest Oncology Group trial.

Authors
S Urba;J Moon;M LeBlanc;J Forman;D Adelstein;P Giri;E Hanna;J Ensley;D Schuller
Journal / Conference
Proc of the American Society of Clinical Oncology 21:230a(#919)
Year
2002
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9451